secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuphoria Therapeutics Inc. (NEUP)
CIK:        0001191070
Form:       8-K
Filed at:   2025-09-16T23:59:59+00:00
Accession:  0001213900-25-087950
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq grants Neuphoria 180-day extension to hold annual meeting, cure listing deficiency
--------------------------------------------------------------------------------

- Nasdaq accepted compliance plan on Sept 10, 2025; new deadline Dec 29, 2025.
- Deficiency for failure to hold annual meeting within 12 months of fiscal year end June 30, 2024.
- Company plans to file 10-K by Sept 29, 2025, then proxy and hold meeting within extension.
- No financial impact disclosed; listing remains under monitoring.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1191070/000121390025087950/0001213900-25-087950-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1191070/000121390025087950/ea0257502-8k_neuphoria.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-087950

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer